Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBT (2016 - 2025)

Solesence (SLSN) has disclosed EBT for 16 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 136.78% year-over-year to -$1.1 million, compared with a TTM value of $1.7 million through Sep 2025, down 36.85%, and an annual FY2024 reading of $4.5 million, up 201.78% over the prior year.
  • EBT was -$1.1 million for Q3 2025 at Solesence, down from $3.1 million in the prior quarter.
  • Across five years, EBT topped out at $3.1 million in Q2 2025 and bottomed at -$2.1 million in Q4 2023.
  • Average EBT over 5 years is $95315.8, with a median of $50000.0 recorded in 2022.
  • The sharpest move saw EBT surged 884.43% in 2021, then plummeted 1969.35% in 2023.
  • Year by year, EBT stood at -$357000.0 in 2021, then tumbled by 460.78% to -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then skyrocketed by 84.4% to -$331000.0 in 2024, then plummeted by 238.37% to -$1.1 million in 2025.
  • Business Quant data shows EBT for SLSN at -$1.1 million in Q3 2025, $3.1 million in Q2 2025, and $80000.0 in Q1 2025.